Tag: NETE

Blue Horseshoe Stocks: TEUM Update & More

Pareteum Corp. TEUM

The last time we mentioned TEUM was December 8th, shortly after which time the stock was trading for as little as .661. At the time the company had no involvement in the trendy cryptocurrency space.

Flash forward to this week, and an announcement that the company is adding blockchain capability for cryptocurrency support on its global cloud billing platform has the stock soaring to new highs.

TEUM hit 3.15 yesterday, which marks an increase of 377% in less than three weeks’ time. Volume for the day was on the order of roughly five times the monthly average.

Bitcoin itself has been making a nice rebound after the pullback which followed its big run to nearly $20K, and there is no reason to suspect that the push toward blockchain related technologies, both cryptocurrency and otherwise, is just a passing fad.

INSYS Therapeutics, Inc. INSY – Options Recap

We made our interest in the INSY 01/19 $8 & $9 Calls known yesterday morning, and it barely took any time at all for our ideas to come to fruition.

As we were mentioning yesterday, the company recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy, and the FDA granted Fast Track status to the ‘drug’ for the treatment of a rare genetic disorder (Prader-Willi).

This news allowed for some very nice moves in our designated contracts. The $8 Calls ran from .35-1.00 for a gain of 186%, while the $9’s traded up from .20-.55, trending up 175% on the day.

Ampio Pharmaceuticals, Inc. AMPE

We also want to swing back to remind our readers of last week’s alert on AMPE. We tagged this play seven days ago (four trading days), and saw it trading for as little as 2.57. As of yesterday’s high of 3.55, the stock had thus far risen by 38%

The stock’s peak PPS represented a new annual high, so we’ll be interested to see how the stock performs in blue skies.

Extended Watchlist:
OTIV, FH, NETE, LFIN, GROW, IDXG, WATT, ATNM

Blue Horseshoe Stocks: Kicking Off the Short Week

INSYS Therapeutics, Inc. INSY

This morning we kick off the holiday shortened week, during a time of year that typically sees subdued activity for the markets as a whole, as people spend time with their families, and stay busy with holiday festivities.

We still strive to identify possible opportunities even in this environment, and the first thing to hit our scanner this morning was INSY. INSYS Therapeutics recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy.

The FDA, we’re learning today, has also granted Fast Track status to INSY for the ‘drug’ for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder. (View PR)

The stock registered its 52-week lows at the beginning of last month, and has been in a general uptrend since, but we’ll be looking for further bullish activity on the heels of this FDA news, both on the stock chart, and in the options chain as a secondary idea. For that, we’ll look to the INSY 01/19 $8 & $9 Calls for opportunities.

DelMar Pharmaceuticals, Inc. DMPI

Speaking of FDA Fast Track designations, we’re looking to DMPI this morning as well, which was granted the status by the FDA for its lead-product cancer treatment, VAL-083.

The chart itself was already set up as a possible bottom play, and despite gapping up considerably on this morning’s news, there is still room to the upside, including a sizable gap that’s been left on the chart since this past spring, the eventual filling of which would spell gains of more than 100% from the current PPS.

Extended Watchlist:
KLXI, EXXI, AEZS, SRAX, IMUC, NETE

Blue Horseshoe Stocks: Winning Options & More

Peer to Peer Network PTOP
.
Yesterday morning, we were just recapping the unreal performance of PTOP subsequent to our initial mention of the stock on November 8th after which time we would observe the stock trading for as little as .0004. It went on to break the 5000% gain mark, but we said we’d stick with it, and once again the stock delivered a solid performance and new highs during yesterday’s session.

PTOP traded in a range from .0152 to .0285, which works out to an intraday move of 88% and a ridiculously big run of 7025% in a span of roughly six weeks!


Options Review

We submitted a couple of fresh options ideas yesterday morning, having seen solid earnings from each of the following companies, and of the six total contracts we highlighted, every last one provided traders with the chance for significant single session profits.

FedEx Corp. FDX – Weekly $245-250 Calls.
$14.50 Calls – Range: 2.92-6.50 – Max Gain: 123%
$15 Calls – Range: 1.33-4.11 – Max Gain: 209%
$15.50 Calls – Range: .59-2.26 – Max Gain: 283%

In the case of FDX, it appears that we could see an extension of these gains before the week is out.

Blackberry Ltd. BB – Weekly $10.50-11.50 Calls
$14.50 Calls – Range: 1.11-1.85 – Max Gain: 67%
$15 Calls – Range: .61-1.40 – Max Gain: 130%
$15.50 Calls – Range: .30-.90 – Max Gain: 200%

Net Element, Inc. NETE

We tagged NETE for observation yesterday, and it too had a solid session. From a low  of 15.18 \the stock traded as high as  24.98, for an intraday move of 65% which came on volume of more than forty-eight times the monthly average.

For a stock in the fifteen dollar range, that is an incredible one day performance, and will leave us interested to track its movements further, going forward. Already in the premarket the stock has pushed as high as 33.44, extending our observed range to 120%

Extended Watchlist:
NVFY, FINL, VSTM, GENE, TROV